Description

The Human TIGIT / CD155 Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between CD155 and its receptor T-cell immunoreceptor with Ig and ITIM domains in the presence of potential inhibitors within 4 hours. 4-8 week development phase.